LINEAGE CELL THERAPEUTICS
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs. The company is focused on developing new therapeutics for age-related degenerative disease. BioTime and its subsidiaries are developing OpRegen® (a cell-based therapy for age-related macular degeneration), therapies for cancer, and arthritis, respectively. Our subsidiary ReCyte Therapeutics is using proprietary technology to reverse the developmental aging of hu... man cells to manufacture young vascular progenitors for the treatment of age-related vascular disease. Relatively near-term product development by BioTime and its subsidiaries include Renevia, a patented hyaluronan-based hydrogel device for cell delivery; PanC-Dx, a blood-based pan-cancer screening diagnostic; and re-starting the embryonic stem cell-based clinical trial for spinal cord injury that was originally begun by Geron, using the stem cell assets acquired from them in 2013. BioTime also markets an FDA-approved blood plasma expander called Hextend®, which is currently marketed in collaboration with Hospira.
LINEAGE CELL THERAPEUTICS
Industry:
Biopharma Biotechnology Environmental Consulting Health Care Medical
Founded:
1990-01-01
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.lineagecell.com
Total Employee:
101+
Status:
Active
Contact:
510-521-3390
Total Funding:
108.81 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
BioVaxys
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.
Calidi Biotherapeutics
Calidi Biotherapeutics is a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cleveland BioLabs
Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications.
Cytrellis Biosystems
Cytrellis is a medical technology company that develops aesthetic devices.
Galapagos
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Histogen
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Kintara Therapeutics
Kintara Therapeutics is a developer of novel cancer therapies for patients with unmet medical needs.
Kite Pharma
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
MiNA Therapeutics
MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms.
PharmaCyte Biotech
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer.
Pregenen
Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Selecta Biosciences
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is a biopharmaceutical company developing drugs to treat oncology and hematology.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Tetra Therapeutics
Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Unicycive Therapeutics
Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-11-08 | Asterias Biotherapeutics | Asterias Biotherapeutics acquired by Lineage Cell Therapeutics | N/A |
| 2012-04-20 | XenneX | XenneX acquired by Lineage Cell Therapeutics | N/A |
| 2011-02-14 | Glycosan | Glycosan acquired by Lineage Cell Therapeutics | N/A |
| 2011-01-28 | Cell Targeting | Cell Targeting acquired by Lineage Cell Therapeutics | 2.2 M USD |
| 2010-04-29 | ES Cell International Pte Ltd. | ES Cell International Pte Ltd. acquired by Lineage Cell Therapeutics | N/A |
Investors List
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Lineage Cell Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Lineage Cell Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Lineage Cell Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-08-02 | AgeX Therapeutics | Lineage Cell Therapeutics investment in Venture Round - AgeX Therapeutics | 10 M USD |
Official Site Inspections
http://www.lineagecell.com Semrush global rank: 2.4 M Semrush visits lastest month: 7.62 K
- Host name: 172.67.142.162
- IP address: 172.67.142.162
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Lineage Cell Therapeutics"
Home - Lineage Cell Therapeutics
May 6, 2024 · Genentech and Lineage are working together to expand benefits of cell therapy to eye diseases We’re teaming up to create allogeneic retinal pigment epithelial (RPE) cells to …See details»
Company - Lineage Cell Therapeutics
Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and …See details»
Lineage Cell Therapeutics - Wikipedia
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated hum…See details»
Lineage Platform - Lineage Cell Therapeutics
With our platform we develop and manufacture specialized, terminally-differentiated human cells from our pluripotent and progenitor cell starting materials.See details»
Our mission is to pioneer a new branch of medicine of allogeneic …
“Cell-based therapies provide the possibility to replace dying or damaged eye cells with new healthy ones. Our aim is to repair the underlying cellular structure of the retina – a thin layer of …See details»
Lineage Cell Therapeutics - LinkedIn
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy...See details»
Corporate Overview - Lineage Cell Therapeutics
Image adapted from scienceofamd.org Photoreceptor recovery •OpRegen is an injection of RPE cells beneath the retina, to replace lost retinal cells, recover function, and preserve or improve …See details»
Lineage Cell Therapeutics, Inc. (LCTX) Company Profile & Overview ...
Nov 21, 2024 · Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for unmet medical needs in the United States and internationally.See details»
Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy …
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary …See details»
OpRegen - Lineage Cell Therapeutics
On December 20, 2021, Lineage entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the …See details»
Lineage Establishes Exclusive Worldwide Collaboration …
Dec 20, 2021 · Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based...See details»
Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord …
Jun 22, 2021 · Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust …See details»
Lineage Cell Therapeutics Announces Pricing of up to $66 Million ...
CARLSBAD, Calif., November 20, 2024 -- (BUSINESS WIRE)-- Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing …See details»
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results …
Mar 13, 2024 · Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel or "off-the-shelf," cell therapies to address unmet medical needs. Lineage’s programs …See details»
Lineage Cell Therapeutics, Inc. (LCTX) - Yahoo Finance Canada
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for unmet medical needs in the United States and internationally.See details»
CITIZENSHIP OR PLACE OF ORGANIZATION
Citizenship or place of organization delaware: number of shares beneficially owned by each reporting person with: 7. sole voting power: 0 8. shared voting power: 41,666,255: 9. sole …See details»
Lineage Cell Therapeutics Announces Pricing of up to $66 Million ...
Nov 20, 2024 · Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel, “off-the-shelf,” cell therapies to address unmet medical needs. Lineage’s programs are …See details»
Media - Lineage Cell Therapeutics
Oct 16, 2024 · Richard Fessler, MD, Professor of Neurosurgery, Rush University Medical School, discusses data seen in the phase 1/2 clinical trial of OPC1 for spinal cord injury (watch on …See details»
Lineage Cell Therapeutics | Carlsbad CA - Facebook
Lineage Cell Therapeutics, Carlsbad, California. 1,234 likes · 2 talking about this · 6 were here. Lineage Cell Therapeutics is a clinical-stage...See details»
OPC1 - Lineage Cell Therapeutics
OPC1 is an oligodendrocyte progenitor cell therapy that is planned to be evaluated in a device safety study, the DOSED study, in subacute and chronic spinal cord injury patients. …See details»